Synopsis of recent research by authors named "Xing-Fu Li"
- Xing-fu Li's recent research primarily focuses on autoimmune diseases, particularly rheumatoid arthritis (RA) and ankylosing spondylitis (AS), investigating the impact of various treatments and associations with biochemical markers such as homocysteine levels.
- His studies highlight the efficacy and safety of targeted therapies, including Baricitinib and bio-similar etanercept, in patients with moderately to severely active RA, showing significant clinical improvements in Chinese populations.
- Li also explores the mechanisms underlying osteoporosis in HIV patients and the expression of immune markers like Tim-3 in systemic lupus erythematosus, contributing to a broader understanding of autoimmune disease pathogenesis and treatment responses.
